GlassScriptPhysician profile
Brian W Zale
NPI 1356396832
$2,096.87
in general payments reported to CMS, 2019-2025
16 companies · $52.21 in 2025
The $52.21 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $456 · 2021: $387 · 2022: $255 · 2023: $97.98 · 2025: $52.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $883.60 | 2019-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $304.28 | 2019-2020 | |
| Trilliant Surgical LLC. | $228.82 | 2019-2020 | |
| Osiris Therapeutics INC. | $143.96 | 2019 | |
| Merck Sharp & Dohme LLC | $129.60 | 2019 | |
| Acera Surgical, INC. | $106.88 | 2020 | |
| Paratek Pharmaceuticals, INC. | $83.43 | 2020-2021 | |
| Medtronic, INC. | $41.13 | 2023 | Intellis Adaptivestim |
| Medinc of Texas | $34.66 | 2025 | |
| Triad Life Sciences INC. | $26.11 | 2022 | |
| Integra Lifesciences Corporation | $22.03 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $21.97 | 2019 | |
| Zyla Life Sciences, INC. | $18.51 | 2019 | |
| Kerecis Limited | $17.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Amgen INC. | $17.55 | 2025 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $16.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Zale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.